The global market enjoys a valuation of US$ 193.8 Million in 2023, and it is further projected to expand at a CAGR of 8.9% over the forecasted years. According to a recent study by Future Market Insights, handheld meters are leading the market with a share of about 45.3% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2023 | US$ 193.8 Million |
| Market Value 2033 | US$ 491.7 Million |
| CAGR 2023 to 2033 | 8.9% |
| Market Share of Top 5 Countries | 57.6% |
| Key Market Players | F. Hoffmann-La Roche AG, Nova Biomedical, COSMED srl, ApexBio, Arkray, Inc., EFK Diagnostics, Sensa Core, Medical Instrumentation Pvt. Ltd., TaiDoc Technology, BST Biosensor Technology, Analox Instruments Limited, and Marshal Scientific LLC |
Serum lactate analyzers, also widely recognized as serum lactate diagnostic tools, are devices that detect the presence of lactate in the blood. A serum lactate analyzer is a diagnostic tool that assesses muscle performance using a small drop of blood. The lactate test is almost painless, but it is also quick and accurate.
Athletes primarily use lactate level measurement to track oxygen levels in muscle fibers and lactate levels in body tissue. For athletes, the serum lactate test is a useful predictor to effective and safe training. It assists an athlete in avoiding under or overtraining, both of which can result in exhaustion.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the market are anticipated to rise at a CAGR of 8.9% between 2023 and 2033, owing to the rising prevalence of various chronic and infectious diseases.
The global market holds around 6.9% share of the overall global SpO2 monitoring market with a value of around US$ 2.8 Billion, in 2022.
One of the key factors propelling the growth of the market in the coming years is the surge in the demand for early diagnosis and treatment due to the increase in chronic conditions like cancer, diabetes etc.
Metabolic disorders, such as diabetes, are becoming increasingly common. This is likely to drive the demand for blood lactate testing equipment, which is also used to monitor blood sugar levels and detect complications in an early stage. An increase in urbanization is expected to boost the demand for lactate testing devices in hospital settings and mobile devices that can be used at home.
According to the The International Diabetes Federation (IDF) 2021, Diabetes affects an estimated 537 million adults aged 20 to 79. The overall number of diabetics is expected to grow to 643 Million by 2030 & 783 Million by 2045. Three out of every four individuals who have diabetes are from low- and middle-income nations. Almost one-half of all adults (240 million) with diabetes are underrecognized. Diabetes claimed the lives of 6.7 million people.
Diabetes accounted for at least USD 966 Billion in health expenditure, accounting for 9% of total adult spending. Type 1 diabetes affects over 1.2 Million children and adolescents aged 0 to 19. Diabetes affects one out of every six live births (21 million). 541 Mn adults are more likely to develop type 2 diabetes.
The rise in prevalence of other chronic diseases, such as cardiovascular diseases and cancer, is also driving the demand for efficient and advanced serum lactate testing such as Lactate Scout 4.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 491.7 million during the year 2033.
The market is anticipated to expand due to a surge in athletics and sports activities, creating a huge opportunity for market players to step into the market.
Athletes and sportspersons require to check their lactate levels during training or a race, as during that time the lactate flows to various parts of the body, including the bloodstream. Serum lactate testing shows accurate levels of lactate, as it is in an equilibrium state in the body. The rise in sports activities and participation of individuals in these activities increases the number of participants who would need to test their lactate levels, as a surge in the level of lactate in the blood could lead to adverse effects in the body.
Appropriate lactate measures are considered markers for accessing the conditioning of the energy systems which aid in predicting the race performance. Hence, a trainer needs to test and measure the lactate levels of a performer.
Therefore, an increase in athletic and sports activities drives the need and usage of lactate meters to test lactate levels before and during the performance. Hence, an increase in sports activities presents lucrative opportunities in the market during the forecast period.
Principal Consultant
The market is expected to grow owing to the lack of precision & device-related issues creating glitches in the market growth. However, some factors limit the market.
Although most of the self-testing devices & kits claim to have high precision, the rate of false negative and false positive results is significant. Accuracy depends on several factors including the type of test, skills and other similar factors.
Patients have shifted from standard lactate testing devices toward modern alternatives that are easily available in the market. The high cost of lactate testing devices, patients' preference for laboratory tests for blood lactate analysis, and the availability of more feasible and trustworthy alternatives are further factors influencing the lower adoption rates of lactate testing devices.
The lack of precision may reduce the uptake of the products and thereby restrain the growth of the serum lactate testing market.
The USA dominates the North American region with a total market share of around 92.6% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
Because of rising technological adoption and increased awareness of the chronic disease, the United States will maintain its lead in the global market.
According to the Centers for Disease Control and Prevention (CDC), shortness of breath and oxygen causes more than 200,000 hospitalisations and 36,000 deaths in the United States each year. According to the American Heart Association's 2017 data, there are 2,353 cardiovascular deaths per day. The American population's growing awareness of cardiac disorders and acceptance of newer technology is a major factor in its dominance in this field.
Germany holds a market share of 24.5 % in 2022 in the European serum lactate testing market, owing to the presence of many established players and the rise of chronic diseases with an increase in the rate of infections is boosting the market for serum lactate testing in Germany. According to an article entitled “Sepsis incidence in Germany and worldwide : Current knowledge and limitations of research using health claims data, 2021”, sepsis is responsible for approximately 20% of all deaths worldwide. A study in Germany based on country-wide admission and discharge data from nearly all German hospitals discovered a sepsis incidence of 158 per 100,000 inhabitants. The increase in septic conditions increases the point-of-care testing market in the given forecasted period.
India holds a share of around 37.2% in the South Asia market in 2022. Both diabetic and immunocompromised patients are currently overrepresented in India. An increase in sports participation has led the serum lactate testing market to grow in the given forecasted period. Diabetes is becoming increasingly prevalent in India. In India, the prevalence of Type 2 diabetes is particularly alarming. According to the International Diabetes Federation's Diabetes Atlas 2021, India accounts for one in every seven adults worldwide who have diabetes.
China has a market share of 60.7%, with a market value of US$ 17.1 Million in the East Asia serum lactate testing market in 2022.
As China's infrastructure matures and offers more device alternatives due to technological advancements, access to serum lactate monitoring devices will increase rapidly. To support the predicted rise of serum lactate testing monitoring, domestic companies specialising in devices for structural heart disorders and other infectious diseases are also expanding quickly.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hand-held meters are expected to give high growth at a CAGR of 8.9% between 2023 and 2033. A hand-held lactate serum testing device is a portable, compact device with is used for point-of-care testing as well while at home. A small amount of blood is required. Capillary action fills the reagent strip. Lactate in the specimen reacts with the strips' reagents. These reagents generate a current when a given voltage is applied. This reaction is calculated amperometric ally and is proportional to the blood sample's lactate concentration. These factors promote product adoption globally.
Serum lactate testing is widely used in the medical intervention segment in patients with cardiac, blood disorders and infectious conditions. It has a market share of 66.5% in the global market in 2022.
Increasing prevalence of metabolic disorders globally will further grow serum lacate testing market in the forecasted period. Cardiovascular diseases (CVD) have emerged as a major cause of disability and death around the world, and metabolic abnormalities such as hypertension, diabetes, and hyperlipidemia dramatically increase the risk of CVD. The most important risk factor for metabolic diseases is age, thus promoting market expansion.
Hospitals hold a market share of 45.3% during the year 2022. Hospitals are the primary places where the point of care testing is in demand. The increase in emergency department visits, and the increase in patient count has been increasing the sales of lactate testing. Owed to comprehensive care within the hospital settings, the segment is set to expand at a lucrative rate over the forecast period.
Serum lactate testing companies are adopting key differentiating strategies such as increasing product pipelines and regulatory approvals, expanding into other regions, and brand management approvals in different regions. Because of increased awareness, the market's dynamics have shifted.
Instances of important developmental strategies used among market participants in the serum lactate testing market are presented below
Similarly, recent developments related to companies manufacturing serum lactate testing products have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | US$ Million for Value & ‘000 Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United kingdom, Germany, Italy, Russia, Spain, France, Benelux, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa and North Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The market is valued at US$ 491.7 million in 2023.
F. Hoffmann-La Roche AG, Nova Biomedical are key market players.
The market is forecast to register a CAGR of 8.9% through 2033.
Hand held meters segment is likely to remain preferred through 2033.
Increase in athletics and sports activities, is encouraging the sales.
1. Executive Summary | Serum Lactate Testing Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development/Innovation Trends
4. Key Success Factors
4.1. Product Adoption /Usage Analysis- Key Statistics
4.2. Product USP Features
4.3. Regulatory Scenario
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Key Promotional Strategies, By Key Manufacturers
4.7. Supply Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Growing Prevalence of Chronic and Infectious Diseases and Government Initiatives
5.2.3. Rising Number of Diagnostic Centers
5.2.4. New Product Launches / Approvals
5.2.5. Strategic Developments by Key Players
5.2.6. Research and Development Activities by Key Players
5.2.7. Rise of Healthcare Spending in Developing Economies
5.2.8. Technological Advancements
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand Volume (‘000 Units) Analysis 2015 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (‘000 Units) Analysis, 2015 to 2022
7.2. Current and Future Market Volume (‘000 Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.1.1. Global Average Pricing Analysis Benchmark
8.2. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Mn) Analysis, 2015 to 2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis By Product, 2015 to 2022
10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Product, 2023 to 2033
10.3.1. Table Top Analyzers
10.3.2. Hand-held Meters
10.3.3. Test Strips
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2015 to 2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Medical Intervention
11.3.1.1. Hypoxia
11.3.1.2. Obstetrics
11.3.1.3. Post-Surgery Infection
11.3.1.4. Others
11.3.2. Sports Application
11.3.3. Veterinary Application
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015 to 2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Diagnostic Laboratories
12.3.3. Sports Institutes
12.3.4. Speciality Clinics
12.3.5. Home Care Settings
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Region, 2015 to 2022
13.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis By Country
14. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
14.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. USA Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Canada Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
15. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
15.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
16. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
16.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. United kingdom
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. United kingdom Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Application
16.8.5.2.3. By End User
16.8.6. BENELUX Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Application
16.8.6.2.3. By End User
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Application
16.8.7.2.3. By End User
17. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
17.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
18.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Thailand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. Indonesia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. Malaysia Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
19. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
19.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2015 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn)Trend and Volume (‘000 Units) Analysis by Market Taxonomy, 2015 to 2022
20.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application
20.8.1.2.3. By End User
20.8.2. Türkiye Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application
20.8.2.2.3. By End User
20.8.3. South Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Application
20.8.3.2.3. By End User
20.8.4. North Africa Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Application
20.8.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players (%)
21.3. Market Presence Analysis
21.3.1. By Regional Footprint of Players
21.3.2. By Product Footprint of Players
21.3.3. By Channel Footprint of Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. F. Hoffmann-La Roche AG
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. SWOT Analysis
22.3.1.5. Key Developments
22.3.1.6. Sales Footprint
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategy
22.3.1.7.2. Product Strategy
22.3.1.7.3. Channel Strategy
22.3.2. Nova Biomedical
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. SWOT Analysis
22.3.2.5. Key Developments
22.3.2.6. Sales Footprint
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategy
22.3.2.7.2. Product Strategy
22.3.2.7.3. Channel Strategy
22.3.3. COSMED srl
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. SWOT Analysis
22.3.3.5. Key Developments
22.3.3.6. Sales Footprint
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategy
22.3.3.7.2. Product Strategy
22.3.3.7.3. Channel Strategy
22.3.4. ApexBio
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. SWOT Analysis
22.3.4.5. Key Developments
22.3.4.6. Sales Footprint
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategy
22.3.4.7.2. Product Strategy
22.3.4.7.3. Channel Strategy
22.3.5. Arkray, Inc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. SWOT Analysis
22.3.5.5. Key Developments
22.3.5.6. Sales Footprint
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategy
22.3.5.7.2. Product Strategy
22.3.5.7.3. Channel Strategy
22.3.6. EFK Diagnostics
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. SWOT Analysis
22.3.6.5. Key Developments
22.3.6.6. Sales Footprint
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategy
22.3.6.7.2. Product Strategy
22.3.6.7.3. Channel Strategy
22.3.7. Sensa Core Medical Instrumentation Pvt. Ltd.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. SWOT Analysis
22.3.7.5. Key Developments
22.3.7.6. Sales Footprint
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategy
22.3.7.7.2. Product Strategy
22.3.7.7.3. Channel Strategy
22.3.8. TaiDoc Technology
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. SWOT Analysis
22.3.8.5. Key Developments
22.3.8.6. Sales Footprint
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategy
22.3.8.7.2. Product Strategy
22.3.8.7.3. Channel Strategy
22.3.9. BST Biosensor Technology
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. SWOT Analysis
22.3.9.5. Key Developments
22.3.9.6. Sales Footprint
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategy
22.3.9.7.2. Product Strategy
22.3.9.7.3. Channel Strategy
22.3.10. Analox Instruments Limited
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. SWOT Analysis
22.3.10.5. Key Developments
22.3.10.6. Sales Footprint
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategy
22.3.10.7.2. Product Strategy
22.3.10.7.3. Channel Strategy
22.3.11. Marshal Scientific LLC
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. SWOT Analysis
22.3.11.5. Key Developments
22.3.11.6. Sales Footprint
22.3.11.7. Strategy Overview
22.3.11.7.1. Marketing Strategy
22.3.11.7.2. Product Strategy
22.3.11.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Serum Lactate Testing Market
